PASG Passage BIO, Inc.

NEUTRAL Impact: 2/10 DEFA14A
Horizon immediate Filed Apr 7, 2026 Processed 2mo ago SEC 0001104659-26-040131
Proxy solicitation materials
Latest settled — T+20d
PASG ▼ -44.37% at T+20d
NEUTRAL call ✗ call lost -44.37% · α vs SPY -54.15% · entry $8.22 → $4.57
Next anchor: T+60d in 22d
Last close $5.47 (close Jun 8) · -33.41% from $8.22 entry
Entry anchored
Apr 6, 03:57 PM ET
via Databento tick
T+1d
+13.09%
call +13.09% · α +10.55%
$9.29
settled 2mo ago
T+5d
+32.20%
call +32.20% · α +26.87%
$10.86
settled 8w ago
T+20d
-44.37%
call -44.37% · α -54.15%
$4.57
settled 5w ago
T+60d
call — · α —
in 22d

Price Chart

Loading chart...

Executive Summary

Passage Bio, Inc. filed a definitive proxy statement for its 2026 Annual Meeting, which includes the election of two Class III directors, ratification of its independent auditor, and approval of executive compensation. This is a routine corporate governance filing.

Actionable Insight

This is a standard proxy filing for an annual shareholder meeting. There are no material financial changes or strategic shifts. Shareholders should review the proxy statement for details on director qualifications and compensation matters, but no significant market impact is expected.

Key Facts

  • Election of two Class III directors: Athena Countouriotis, M.D. and Sandip Kapadia
  • Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2026
  • Approval of executive officer compensation on a non-binding advisory basis
  • Approval of frequency for future advisory votes on executive compensation

Financial Impact

Routine corporate governance with no direct financial impact

governanceexecutive compensation

Risk Factors

  • None disclosed in this filing
  • Standard risks associated with any biotechnology company

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-040131
Document: 0001104659-26-040131-index-headers.html0001104659-26-040131
Document: 0001104659-26-040131-index.html0001104659-26-040131
Document: 0001104659-26-040131.txt0001104659-26-040131
5 reports for PASG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PASG — sortable, filterable
Type Now
May 27, 2026
13d ago
8-K
BEARISH ★ 6/10
$5.71 $6.00▼ −5.08%▼ −4.76%$5.47 (+4.20%)
Apr 20, 2026
7w ago
8-K
MIXED ★ 6/10
$6.25 $5.71▼ −8.64%▼ −9.55%$5.47 (−12.48%)
Apr 20, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.25 $5.71▼ −8.64%▼ −9.55%$5.47 (−12.48%)
Apr 7, 2026
9w ago
DEFA14A
NEUTRAL ★ 2/10
$8.22 $10.86▲ +32.20%▲ +26.87%$5.47 (−33.41%)
Mar 3, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$8.00 $8.51▲ +6.38%▲ +6.85%$5.47 (−31.63%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access